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dence of short term (6-months) MACE after PCI. Measuring TnI value
after PCI might be easy-to-use predictor for post-procedural MACE
and patient prognosis.
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BACKGROUND It is well known that low-density lipoprotein
cholesterol (LDL-C) is a risk factor for atherosclerosis. However, the
relationship between admission LDL levels and clinical outcome in
patients underwent percutaneous coronary intervention (PCI)
has not been established. The aim of this study was to evaluate
the effect of admission LDL-C on short- and long-term clinical
outcomes.
METHODS Among patients underwent PCI from single center pro-
spective registry, total 2,638 patients without history of dyslipide-
mia and with fasting lipid proﬁles measured within 24 hours of
admission were selected for analysis. Patients were divided into 4
groups according to the quartile of LDL-C as: Q1 (<86 mg/dl; n ¼
655), Q2 (86 to 109 mg/dl; n ¼ 657), Q3 (110 to 134 mg/dl; n ¼ 655),
and Q4 (LDL-C >134; n ¼ 671). Primary endpoint was patient-ori-
ented composite outcome (POCO) consisted with any death,
myocardial infarction, and any revascularization for 3-year of
follow-up. Secondary endpoint was any death at 30 days after
index PCI.
RESULTS When compared with other groups, patients in Q1 group
were older and thinner. The incidence of hypertension, diabetes,
chronic kidney disease, previous myocardial infarction, previous PCI
was higher in Q1 group. The incidence of myocardial infarction was
similar among groups. Although, the rate of multi-vessel disease
and multi-vessel PCI was similar among groups, PCI for chronic
total occlusion was most frequent in Q1 group. The POCO was
highest in Q1 group (22.3% vs. 19.3% vs. 16.9% vs. 17.3%, log-rank
p ¼ 0.015; Figure) and mortality at 30 days was also higher in Q1
group (7.0% vs. 3.3% vs. 2.7% vs. 2.4%, p <0.001). After exclusion
the patients with mortality at 30 days, the POCO was not different
among groups (16.4% vs. 16.5% vs. 14.6% vs. 15.3%, log-rank p ¼
0.651). However, LDL-C was not an independent predictor for both
endpoints on multivariate analysis.CONCLUSION In our registry, low LCL-C on admission was associated
with 30-day mortality but not with long-term clinical outcome.
However, this ﬁnding is related to confounding by baseline charac-
teristics. Thus, more intensive lipid lowering therapy may results in
better clinical outcomes.
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BACKGROUND Hypertension (HTN) is known to be a risk factor of
signiﬁcant coronary artery disease (CAD). However, currently there is
no enough available data with larger study population with long-term
clinical outcomes of signiﬁcant coronary artery spasm (CAS) patients
(pts) with HTN in real world clinical practice.
METHODS A total of 3,349 consecutive pts without signiﬁcant CAD
underwent acetylcholine (Ach) provocation test and only pts with
signiﬁcant CAS were enrolled. Signiﬁcant CAS was deﬁned as > 70% of
narrowing by incremental intracoronary injection of 20, 50 and 100 mg
into left coronary artery. Pts were divided into two groups based on
the presence of HTN: the HTN group (n¼1,489), the Normotensive
group (n¼1,860). To adjust potential confounders, a propensity score
matched (PSM) analysis was performed using the logistic regression
model.
RESULTS After PSManalysis, 2 propensity-matched groups (1,143pairs,
n ¼ 2,286, C-statistic¼0.720) were generated and, the baseline charac-
teristics of the two groups were balanced. In clinical outcomes up to5-
year, there were similar incidence of individual hard endpoints
including mortality, myocardial infarction, revascularization and
recurrent angina requiring repeat coronary angiography. Hypertension
was not an independent predictor of adverse clinical outcomes in pts
with CAS (Table).
CONCLUSION Despite the expected endothelial dysfunction, hy-
pertension was not associated with a worsening factor for adverse
clinical outcomes in pts with signiﬁcant CAS documented by
intracoronary Achprovocation test, suggesting that the mechanisms
and risk factors of CAS may be different from those of atheroscle-
rotic CAD.
